Pacira Pharmaceutical’s Scibetta Joins Maverick Therapeutics as CEO

Xconomy San Francisco — 

James Scibetta has joined Maverick Therapeutics as CEO and member of the Brisbane, CA, biotech’s board of directors. Scibetta comes to Maverick from Parsippany, NJ-based Pacira Pharmaceuticals (NASDAQ: PCRX), where he was president. Earlier this year, Takeda Pharmaceutical signed Maverick on to a five-year, $125 million partnership pursuing new cancer immunotherapies.